Higher Dosing 'Difficult to Straddle'

Article

Chicago - Escalating doses of an antibody to CTLA-4 in conjunction with a peptide vaccine showed the induction of antigen-specific immune responses and potential evidence of autoimmunity in patients with stage III/IV resected melanoma, according to Jeffrey M. Weber, M.D., Ph.D.

Related Videos
Related Content

Abeona Submits Biologics License Application to FDA for EB-101

September 26th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Severe Psoriasis Associated With Higher Risk of Heart Disease

September 26th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Expert Perspectives Into Empowering Patients With OTC Relief

September 25th 2023

Pointers With Portela: Treating Fungal Acne

September 25th 2023

Abeona Submits Biologics License Application to FDA for EB-101

September 26th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Severe Psoriasis Associated With Higher Risk of Heart Disease

September 26th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Expert Perspectives Into Empowering Patients With OTC Relief

September 25th 2023

Pointers With Portela: Treating Fungal Acne

September 25th 2023

Abeona Submits Biologics License Application to FDA for EB-101

September 26th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Severe Psoriasis Associated With Higher Risk of Heart Disease

September 26th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Expert Perspectives Into Empowering Patients With OTC Relief

September 25th 2023

Pointers With Portela: Treating Fungal Acne

September 25th 2023
© 2023 MJH Life Sciences

All rights reserved.